Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model
Abstract Background Hydroxyethyl Starch (HES) 130/0.4 (6%) is a commonly used intravascular volume expander with anti-inflammatory and antioxidant properties. In this study, we aimed to compare the histopathologic activity of HES 130/0.4 (6%) with various widely-used agents in pleurodesis. Methods F...
Main Authors: | Hasan Oğuz Kapicibasi, Hasan Ali Kiraz, Nazli Demir Gök |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-020-01260-1 |
Similar Items
-
Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
by: Chung-Sik Oh, et al.
Published: (2012-04-01) -
Thromboelastometric assessment of hemostasis following hydroxyethyl starch (130/0.4) administration as a constant rate infusion in hypoalbuminemic dogs
by: Angelica Botto, et al.
Published: (2018-01-01) -
Stage 1-Biomarkers of Kidney Injury in Dogs Undergoing Constant Rate Infusion of Hydroxyethyl Starch 130/0.4
by: Barbara Bruno, et al.
Published: (2021-08-01) -
Adverse Reactions to 6% Hydroxyethyl Starch in the Operating Room
by: Shaswat Kumar Pattnaik, et al.
Published: (2013-11-01) -
Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials
by: Yi Xu, et al.
Published: (2021-05-01)